News
Global drugmakers eye more China biotech deals after record year
Executives seek “skin in the game” despite signs of a stock market cooldown.
Content Partner • [email protected]
As part of 36Kr’s ongoing partnership with Nikkei, you can read selected content from Nikkei Asia on KrASIA.
News
Executives seek “skin in the game” despite signs of a stock market cooldown.